Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonists
Author:
Funder
National Institute of Health
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10549-019-05279-9.pdf
Reference30 articles.
1. Santos R, Ursu O, Gaulton A, Bento AP, Donadi RS, Bologa CG, Karlsson A, Al-Lazikani B, Hersey A, Oprea TI, Overington JP (2017) A comprehensive map of molecular drug targets. Nat Rev Drug Discov 16(1):19–34. https://doi.org/10.1038/nrd.2016.230
2. Schierle S, Merk D (2018) Development of nuclear receptor modulators. In: Mavromoustakos T, Kellici TF (eds) Rational drug design: methods and protocols, vol 1824. Methods in molecular biology. Springer, New york, pp 245–260
3. Jordan VC (2003) Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents. J Med Chem 46(7):1081–1111. https://doi.org/10.1021/jm020450x
4. Jordan VC (2007) SERMs: meeting the promise of multifunctional medicines. J Natl Cancer Inst 99(5):350–356. https://doi.org/10.1093/jnci/djk062
5. Jeong Y, Xie Y, Xiao G, Behrens C, Girard L, Wistuba II, Minna JD, Mangelsdorf DJ (2010) Nuclear receptor expression defines a set of prognostic biomarkers for lung cancer. PLoS Med 7(12):e1000378. https://doi.org/10.1371/journal.pmed.1000378
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Natural products and synthetic analogs as selective orphan nuclear receptor 4A (NR4A) modulators;HISTOL HISTOPATHOL;2024
2. Thioredoxin Domain Containing 5 (TXNDC5): Friend or Foe?;Current Issues in Molecular Biology;2024-04-04
3. Bis-Indole Derivatives as Dual Nuclear Receptor 4A1 (NR4A1) and NR4A2 Ligands;Biomolecules;2024-02-27
4. An efficient synthesis and anticancer evaluation of 1,2,3-triazolo-indole-2-carboxylate derivatives;Results in Chemistry;2024-01
5. 3,3′-Diindolylmethane and indole-3-carbinol: potential therapeutic molecules for cancer chemoprevention and treatment via regulating cellular signaling pathways;Cancer Cell International;2023-08-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3